IDA blend vs Togo: Antiretroviral therapy coverage
IDA blend
81.2%
in 2024
Togo
92.0%
in 2024
IDA blend rank
13th
Togo rank
14th
Antiretroviral therapy coverage over time
- IDA blend
- Togo
How they compare
Togo currently reports 92.0% against 81.2% in IDA blend, a difference of 10.8%.
That makes Togo's figure about 1.1 times IDA blend's.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was IDA blend ahead.
IDA blend ranks 13th and Togo ranks 14th of 23 groups.
Across the 3 decades both report, IDA blend averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | IDA blend | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 4.6% | 0.7% | IDA blend |
| 2010s | 45.0% | 44.8% | 0.2% | IDA blend |
| 2020s | 75.2% | 84.0% | 8.8% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, IDA blend or Togo?
- Togo, at 92.0% against 81.2% in IDA blend as of 2024.
- What is the difference in antiretroviral therapy coverage between IDA blend and Togo?
- 10.8%, with Togo ahead.
- How many years of comparable data are there for IDA blend and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA blend and Togo rank globally for antiretroviral therapy coverage?
- IDA blend ranks 13th and Togo ranks 14th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.